New weight-loss drugs in the works will offer more choices beyond GLP-1 options Wegovy and Zepbound. What to know about ...
Patients who stop taking popular injectable weight-loss medications typically regain much of the weight they lost within two ...
A study by the financial firm Jefferies highlights a surprising perk for carriers: lower fuel costs as slimmer passengers ...
Low energy and “Ozempic face” can be the downsides for people on GLP-1s, the increasingly popular drugs that go by the names Ozemic, Wegovy and Mounjaro.
People using weight loss drugs such as Ozempic have been complaining of an unusual impact it has been having on the ...
With more and more Americans using weight loss medications, many restaurants are looking to adapt, providing more options ...
As obesity rates among Americans drop and weight loss drugs lead to a slimmer society, airlines could save on fuel costs, ...
Weight loss jabs may have helped obesity patients shed kilos, but a new review finds that this weight is regained within two ...
Ozempic, a semaglutide drug originally developed for type-2 diabetes, has been in the news as a fast-track weight-loss ...
U.S. airline companies stand to save hundreds of millions each year from Americans losing weight thanks to GLP-1 drugs, ...
The Better Business Bureau received multiple reports from Wisconsin consumers who were sold discounted diet medication.
Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results